Official UK procurement notice
Generic Injections/Infusions 4 · UK public procurement notice
Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)
What is being bought
Published requirement descriptionGeneric Injections/Infusions 4
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- Price: 30
- VFM: 20
- Price Stability: 6
- Minimum Order: 4
Published award criteria (5)
- Quality: Pass/Fail
- Price: 30
- VFM: 20
- Price Stability: 6
- Minimum Order: 4
- Price carries 60 of 60 points: a 10% discount moves about 6 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 12 Jul 2021, 22:45 BST
- Last source update
- 12 Jul 2021, 22:45 BST
- Authority reference
PAD-OJEU-45767- FTS notice number
2021/S 000-016270- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02c700Find a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Ferring Pharmaceuticals LimitedGeneric Injectons/Infusions 4 | £44,040 † | — | Awarded |
| Altan Pharma Ltd | £79,463 † | — | Awarded |
| B. Braun Medical Limited | £40,507 † | — | Awarded |
| Baxter Health Care Limited | £131,294 † | — | Awarded |
| Fresenius Kabi Limited | £80,893 † | — | Awarded |
| hameln pharma ltd | £36,818 † | — | Awarded |
| medac Pharma LLP | £44,114 † | — | Awarded |
| Orion Pharma UK Ltd | £20,860 † | — | Awarded |
| Panpharma UK Ltd | £11,244 † | — | Awarded |
| Ranbaxy UK Limited (Sun Pharma) | £108,124 † | — | Awarded |
11 further award records carry no date or value.
Contracts
Generic Injectons/Infusions 4 · Ferring Pharmaceuticals Limited
- Signed
- 30 Jun 2021
- Value
- £44,040
- Status
- active
Generic Injections/Infusions 4 · Altan Pharma Ltd
- Signed
- 30 Jun 2021
- Value
- £79,463
- Status
- active
Generic Injections/Infusions 4 · B. Braun Medical Limited
- Signed
- 30 Jun 2021
- Value
- £40,507
- Status
- active
Generic Injections/Infusions 4 · Baxter Health Care Limited
- Signed
- 30 Jun 2021
- Value
- £131,294
- Status
- active
Generic Injections/Infusions 4 · Fresenius Kabi Limited
- Signed
- 30 Jun 2021
- Value
- £80,893
- Status
- active
Generic Injections/Infusions 4 · hameln pharma ltd
- Signed
- 30 Jun 2021
- Value
- £36,818
- Status
- active
Generic Injections/Infusions 4 · medac Pharma LLP
- Signed
- 30 Jun 2021
- Value
- £44,114
- Status
- active
Generic Injections/Infusions 4 · Orion Pharma UK Ltd
- Signed
- 30 Jun 2021
- Value
- £20,860
- Status
- active
Generic Injections/Infusions 4 · Panpharma UK Ltd
- Signed
- 30 Jun 2021
- Value
- £11,244
- Status
- active
Generic Injections/Infusions 4 · Ranbaxy UK Limited (Sun Pharma)
- Signed
- 30 Jun 2021
- Value
- £108,124
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £32,361
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £163,195
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £145,338
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £42,677
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £360,540
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £50,275
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £185,553
- Status
- active
Generic Injections/Infusions 4
- Signed
- 30 Jun 2021
- Value
- £47,731
- Status
- active
Generic Injections/Infusions 4
- Signed
- 3 Jun 2021
- Value
- £13,153
- Status
- active
Generic Injections/Infusions 4
- Signed
- 3 Jun 2021
- Value
- £29,716
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 31bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
Bidders & participating suppliers
21 commercial parties on the notice- Accord-UK LtdAwarded supplier
- Altan Pharma LtdAwarded supplier
- B Braun Medical LtdAwarded supplier
- Baxter Health Care LimitedAwarded supplier
- Ferring Pharmaceuticals LtdAwarded supplier
- Fresenius Kabi LtdAwarded supplier
- Hameln Pharma LtdAwarded supplier
- MartindaleAwarded supplier
- Medac Pharma LLPAwarded supplier
- Mercury Pharmaceuticals LtdAwarded supplier
Show 11 more suppliers
- MylanAwarded supplier
- Orion Pharma Uk LtdAwarded supplier
- Panpharma UK LtdAwarded supplier
- Pfizer LimitedAwarded supplier
- Ranbaxy UK Limited (Sun Pharma)Awarded supplier
- Sandoz LtdAwarded supplier
- Seacross Pharmaceuticals LtdAwarded supplier
- Teva UK LtdAwarded supplier
- Tillomed Laboratories LtdAwarded supplier
- Wockhardt UK LimitedAwarded supplier
- Zentiva Pharma UK LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.